3 of the best ASX 200 shares to buy now with $5,000

Investors with money to invest might want to check out these shares that analysts rate as buys.

| More on:
Three happy office workers cheer as they read about good financial news on a laptop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Do you have $5,000 ready to invest? Whether you're topping up your portfolio or getting started on your ASX journey, choosing the right shares now could make a meaningful difference over the long term.

In today's uncertain market, quality matters. That means focusing on companies with strong fundamentals, durable earnings, and the ability to grow through cycles.

With that in mind, here are three of the best ASX 200 shares to consider buying right now according to analysts — each offering something a little different, but all built for long-term success. They are as follows:

CSL Ltd (ASX: CSL)

CSL is one of the Australian share market's most iconic companies — and for good reason. This biotech giant develops life-saving therapies across immunology, vaccines, and rare diseases.

The company already has a world class product portfolio, but this doesn't stop it from investing US$1 billion+ into R&D activities each year. This ensures that the company is at the forefront of the industry and has a pipeline of potentially lucrative products to drive its future growth.

Analysts are feeling very positive about the company's outlook and are forecasting double-digit earnings growth in the coming years thanks to the key CSL Behring plasma business.

Bell Potter feels that its shares are cheap based on this growth outlook. As a result, it has put a buy rating and $335.00 price target on its shares.

Pro Medicus Ltd (ASX: PME)

Another ASX 200 share to buy with the $5,000 is Pro Medicus. It is a high-margin, founder-led business that provides advanced imaging software to some of the world's leading hospitals. Its Visage platform helps radiologists analyse medical images faster and more efficiently — a critical need in modern healthcare.

Backed by long-term contracts, Pro Medicus generates strong recurring revenue, incredible operating margins, and returns on capital most companies can only dream of.

And while it trades at a premium, this is arguably justified given its quality and long term growth potential.

Goldman Sachs sees plenty of upside for investors. The broker has put a buy rating and $309.00 price target on its shares.

Woolworths Group Ltd (ASX: WOW)

Finally, Woolworths could be an ASX 200 share to buy according to analysts.

When markets get rocky, Woolworths is the kind of business investors tend to lean on. With a dominant position in Australian supermarkets, a strong loyalty program, and reliable cash flow, it offers defensive stability with modest growth.

While it may not deliver the same excitement as a tech stock, its steady dividends, strong market position and brand loyalty make it a great anchor for any portfolio.

Goldman Sachs is also bullish on this one. It has a buy rating and $36.50 price target on its shares.

Motley Fool contributor James Mickleboro has positions in CSL and Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Goldman Sachs Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended CSL and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

A group of people in suits watch as a man puts his hand up to take the opportunity.
Blue Chip Shares

The ASX blue chip shares I'd trust with my money

Do you have money to invest? Here are three blue chips you can trust.

Read more »

Increasing stack of blue chips with a rising red arrow.
Blue Chip Shares

2 ASX blue-chip shares offering big dividend yields

I’m backing these two businesses as appealing dividend stocks.

Read more »

Green arrow going up on stock market chart, symbolising a rising share price.
Blue Chip Shares

3 ASX 200 shares this fund manager says are buys for 2026

These stocks could be the best blue-chips to own.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Blue Chip Shares

3 ASX blue-chip shares I'd buy with $10,000 right now

These stocks are among Australia’s biggest businesses and have a good outlook.

Read more »

Happy work colleagues give each other a fist pump.
Blue Chip Shares

Where to invest $5,000 in ASX 200 shares to try and beat the market

Let's see what makes these shares potential market-beaters.

Read more »

Happy man on a supermarket trolley full of groceries with a woman standing beside him.
Blue Chip Shares

Are Woolworths shares a blue-chip buy?

Would I buy this supermarket giant's shares? Here's my verdict.

Read more »

A shocked man holding some documents in the living room.
Blue Chip Shares

Why is everyone talking about the Wesfarmers share price this week?

The retail giant is in the spotlight this week.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Blue Chip Shares

3 ASX shares I would hold for the next 10 years

There's a reason why I would hold these shares for the long term.

Read more »